202 related articles for article (PubMed ID: 21719443)
21. Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's disease.
Sodders MJ; Avila-Pacheco J; Okorie EC; Shen M; Kumari N; Marathi A; Lakhani M; Bullock K; Pierce K; Dennis C; Jeanfavre S; Sarkar S; Scherzer CR; Clish C; Olsen AL
bioRxiv; 2024 Jun; ():. PubMed ID: 38798570
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of the Cdk5 activator-like protein, Cdk5α, causes neurodegeneration, in part by accelerating the rate of aging.
Spurrier J; Shukla AK; McLinden K; Johnson K; Giniger E
Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29469033
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson's disease.
de Freitas Silva M; Juliet Cristancho Ortiz C; Ferreira Coelho L; Pruccoli L; Pagliarani B; Pisani L; Catto M; Poli G; Tuccinardi T; Cardoso Vilela F; Giusti-Paiva A; Amaral Alves M; Ribeiro de Souza HM; Tarozzi A; Silva Gontijo V; Viegas C
Bioorg Chem; 2024 Jun; 150():107587. PubMed ID: 38941700
[TBL] [Abstract][Full Text] [Related]
24. Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes.
Rahman MM; Sykiotis GP; Nishimura M; Bodmer R; Bohmann D
Aging Cell; 2013 Aug; 12(4):554-62. PubMed ID: 23521918
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress.
Tsakiri EN; Sykiotis GP; Papassideri IS; Gorgoulis VG; Bohmann D; Trougakos IP
FASEB J; 2013 Jun; 27(6):2407-20. PubMed ID: 23457214
[TBL] [Abstract][Full Text] [Related]
26. Assessing neurodegenerative phenotypes in Drosophila dopaminergic neurons by climbing assays and whole brain immunostaining.
Barone MC; Bohmann D
J Vis Exp; 2013 Apr; (74):e50339. PubMed ID: 23644755
[TBL] [Abstract][Full Text] [Related]
27. Towards a systems-level understanding of aging and cancer: an interview with Dirk Bohmann.
Bohmann D; Dhillon P
Dis Model Mech; 2014 May; 7(5):499-502. PubMed ID: 24795432
[TBL] [Abstract][Full Text] [Related]
28. Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging.
Tsakiri EN; Sykiotis GP; Papassideri IS; Terpos E; Dimopoulos MA; Gorgoulis VG; Bohmann D; Trougakos IP
Aging Cell; 2013 Oct; 12(5):802-13. PubMed ID: 23738891
[TBL] [Abstract][Full Text] [Related]
29. Genetic modifiers of synucleinopathies-lessons from experimental models.
Lee RMQ; Koh TW
Oxf Open Neurosci; 2023; 2():kvad001. PubMed ID: 38596238
[TBL] [Abstract][Full Text] [Related]
30. A Simple Immunofluorescence Method to Characterize Neurodegeneration and Tyrosine Hydroxylase Reduction in Whole Brain of a
Chaurasia R; Ayajuddin M; Ratnaparkhi GS; Lingadahalli SS; Yenisetti SC
Bio Protoc; 2024 Feb; 14(4):e4937. PubMed ID: 38405079
[TBL] [Abstract][Full Text] [Related]
31. Analysis of α-syn and
Narwal S; Singh A; Tare M
Front Cell Neurosci; 2023; 17():1295805. PubMed ID: 38239290
[TBL] [Abstract][Full Text] [Related]
32. Behavioral and histological assessment of a novel treatment of neuroHIV in humanized mice.
Levine AJ; Thadani C; Soontornniyomkij V; Lopez-Aranda MF; Mesa YG; Kitchen S; Rezek V; Silva A; Kolson DL
Res Sq; 2023 Dec; ():. PubMed ID: 38168407
[TBL] [Abstract][Full Text] [Related]
33. Senolytic and senomorphic secondary metabolites as therapeutic agents in
Miller SJ; Darji RY; Walaieh S; Lewis JA; Logan R
Front Neurol; 2023; 14():1271941. PubMed ID: 37840914
[No Abstract] [Full Text] [Related]
34. Fluorescence microscopy-based sensitive method to quantify dopaminergic neurodegeneration in a
Ayajuddin M; Chaurasia R; Das A; Modi P; Phom L; Koza Z; Yenisetti SC
Front Neurosci; 2023; 17():1158858. PubMed ID: 37434762
[TBL] [Abstract][Full Text] [Related]
35. The Role of Nrf2/sMAF Signalling in Retina Ageing and Retinal Diseases.
Zhang J; Zhang T; Zeng S; Zhang X; Zhou F; Gillies MC; Zhu L
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371607
[TBL] [Abstract][Full Text] [Related]
36. Asymmetric Presynaptic Depletion of Dopamine Neurons in a
Zhang J; Lentz L; Goldammer J; Iliescu J; Tanimura J; Riemensperger TD
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239942
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease.
He T; Lin X; Su A; Zhang Y; Xing Z; Mi L; Wei T; Li Z; Wu W
Front Pharmacol; 2023; 14():1117337. PubMed ID: 37234707
[TBL] [Abstract][Full Text] [Related]
38. Sexual dysfunction precedes motor defects, dopaminergic neuronal degeneration, and impaired dopamine metabolism: Insights from
Koza Z; Ayajuddin M; Das A; Chaurasia R; Phom L; Yenisetti SC
Front Neurosci; 2023; 17():1143793. PubMed ID: 37025374
[TBL] [Abstract][Full Text] [Related]
39. The Relationship between Procyanidin Structure and Their Protective Effect in a Parkinson's Disease Model.
Chen J; Chen Y; Zheng Y; Zhao J; Yu H; Zhu J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956957
[TBL] [Abstract][Full Text] [Related]
40. Normal and Pathological NRF2 Signalling in the Central Nervous System.
Heurtaux T; Bouvier DS; Benani A; Helgueta Romero S; Frauenknecht KBM; Mittelbronn M; Sinkkonen L
Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
